About this Event
Welcome to the 6th Global IR @JPM 2026!
Join us for an exciting in-person event at the Town Hall(555 California St) where innovative companies will showcase their investment opportunities. This is a fantastic opportunity to network with professionals and gain valuable knowledge to enhance your IR strategies. Don't miss out on this unique event!
Meet promising Korean and International Biotech Startups and investors, seize collaboration opportunities.
Event Highlights:
- 10 Emerging Life Sciences Companies Presenting
- Jury of VC and Institutional Investors Providing Insightful Feedback
- Panel Discussion on the 2026 Bio Industry Outlook
- Case Study on Cross-Border Success
Don't miss out on this unique chance to take your business to the next level. See you there!
Agenda
🕑: 02:00 PM - 02:30 PM
Panel Discussion 1: Going ‘Golden’: How Asian Biotechs Can Attract Global VCs
Host: Jeff Cranmer, Executive Editor of BioCentury
Info: Sourcing innovation from Asia has been the talk of hallway conversations from JPM ‘25 to Jefferies ‘25. Much of the news flow has been about cross-border licensing deals and NewCos. What will it take for Western VCs to invest directly in biotechs from South Korea and beyond?
🕑: 02:30 PM - 03:30 PM
IR Pitching 1(5 companies)
🕑: 03:30 PM - 04:00 PM
Panel Discussion 2: What to Expect From FDA in 2026, MFN and Beyond
Host: Josh Hofheimer, Partner of Sidley Austin
Info: As FDA moves into a pivotal regulatory year, significant policy shifts are on the horizon. This discussion will explore the agency’s expected 2026 agenda, the evolving MFN framework, and the reinvigorated BioSecure Act, along with other congressional initiatives poised to influence product development, global operations, and market access.
🕑: 04:00 PM - 05:00 PM
IR Pitching 2 (5 companies)
Event Venue & Nearby Stays
555 California St, 555 California Street, San Francisco, United States
USD 0.00
